
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. (LYEL)
WebsitePrice
Market cap
Next catalystDec 12, 2026Ronde-cel — Phase 1/2 second-line cohort · Phase 1/2 dataCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved